Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2493${count})

  • Novel Hypotheses in Parkinson's Disease, 2010
    Quantitative Analysis of S-Nitrosylated Proteins in Parkinson's Disease

    Objective/Rationale: 
    Free radical stress may play a role in pathogenesis of Parkinson’s disease (PD).  In this project, we study how free radicals related to reactive nitrogen (N) and oxygen (O)...

  • Understanding LRRK2 Biology, 2010
    Functional Analysis of LRRK2: Focus on Autophagy

    Promising Outcomes of Original Grant:
    The overall purpose of the original grant was to utilize pre-clinical and human model systems to better understand LRRK biology. The original aims proposed were to...

  • Neurotrophic Factor Therapies for Parkinson's Disease, 2010
    CDNF (Cerebral Dopamine Neurotrophic Factor) for Therapy of Parkinson's Disease

    Objective/Rationale:
    CDNF protein is expressed in human brain, acts differently from known neurotrophic factors and can protect and repair dopamine neurons in two pre-clinical models of Parkinson’s...

  • Target Validation, 2009
    Testing PDE-1 Inhibitor in MPTP-treated Macaques

    Promising Outcomes of Original Grant:
    Our goal is to develop novel therapeutic molecules that promote normal dopamine neurotransmission in the brain affected by PD. We hypothesize that these molecules...

  • Rapid Response Innovation Awards, 2010
    Selective Neuroprotective Effects of the S18Y Polymorphic Variant of UCH-L1

    Promising Outcomes of Original Grant:
    We were able to replicate in an in vivo setting in the nigrostriatal system our previous observation in neuronal cell cultures that lack of UCH-L1 did not alter...

  • Rapid Response Innovation Awards, 2010
    Ghrelin - a Peripheral, Preclinical Biomarker for Parkinson's Disease

    Promising Outcomes of Original Grant:
    In our original grant we investigated serum concentrations of the hormone ghrelin in the fasting state and at different time points after a standardized test meal...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.